AC Immune SA - SHS (ACIU)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / SHS
Total 13F shares
20,709,959
Share change
+323,179
Total reported value
$101,062,895
Put/Call ratio
36%
Price per share
$4.88
Number of holders
49
Value change
+$1,419,309
Number of buys
28
Number of sells
17

Institutional Holders of AC Immune SA - SHS (ACIU) as of Q3 2020

As of 30 Sep 2020, AC Immune SA - SHS (ACIU) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,709,959 shares. The largest 10 holders included BVF INC/IL, Temasek Holdings (Private) Ltd, Avidity Partners Management LP, Artal Group S.A., Prosight Management, LP, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, Aquilo Capital Management, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.